Risk factors for poor renal prognosis in children with hemolytic uremic syndrome

被引:37
作者
Gianviti, A
Tozzi, AE
De Petris, L
Caprioli, A
Ravà, L
Edefonti, A
Ardissino, G
Montini, G
Zacchello, G
Ferretti, A
Pecoraro, C
De Palo, T
Caringella, A
Gaido, M
Coppo, R
Perfumo, F
Miglietti, N
Ratsche, I
Penza, R
Capasso, G
Maringhini, S
Li Volti, S
Setzu, C
Pennesi, M
Bettinelli, A
Peratoner, L
Pela, I
Salvaggio, E
Lama, G
Maffei, S
Rizzoni, G
机构
[1] Bambino Gesu Childresn Hosp, Div Nephrol & Dialysis, Rome, Italy
[2] Inst Sci Res, Rome, Italy
[3] Ist Super Sanita, I-00161 Rome, Italy
[4] De Marchi Pediat Clin, Dialysis Unit, Milan, Italy
[5] Univ Padua, Dept Pediat, Padua, Italy
[6] Santobono Hosp, Div Nephrol & Dialysis, Naples, Italy
[7] Regina Margherita Hosp, Div Nephrol & Dialysis, Turin, Italy
[8] Giovanni XXIII Hosp, Div Nephrol & Dialysis, Bari, Italy
[9] G Gaslini Hosp, Div Nephrol & Dialysis, Genoa, Italy
[10] Spedali Civil Brescia, Pediat Clin, I-25125 Brescia, Italy
[11] Univ Ancona, Pediat Clin, Ancona, Italy
[12] Univ Bari, Pediat Clin, Bari, Italy
[13] Univ Naples, Div Nephrol & Dialysis, Naples, Italy
[14] Di Cristina Hosp, Div Nephrol, Palermo, Italy
[15] Univ Catania, Pediat Clin, Catania, Italy
[16] Brotzu Hosp, Div Nephrol, Cagliari, Italy
[17] Burlo Hosp, Trieste, Italy
[18] San Leopoldo Mant Hosp, Pediat Unit, Merate, Italy
[19] Civile Hosp, Pediat Clin, Pordenone, Italy
[20] Meyer Hosp, Pediat Clin, Florence, Italy
[21] Catholic Univ, Pediat Clin, Rome, Italy
[22] Univ Naples Federico II, Pediat Clin, Naples, Italy
[23] Univ Perugia, Pediat Clin, I-06100 Perugia, Italy
关键词
hemolytic uremic syndrome; Shiga toxin-producing Escherichia coli; prognostic factors; long-term outcome; classification; atypical hemolytic uremic syndrome;
D O I
10.1007/s00467-003-1262-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Many factors have been proposed as predictors of poor renal prognosis in children with hemolytic uremic syndrome (HUS), but their role is still controversial. Our aim was to detect the most reliable early predictors of poor renal prognosis to promptly identify children at major risk of bad outcome who could eventually benefit from early specific treatments, such as plasmapheresis. Prognostic factors identifiable at onset of HUS were evaluated by survival analysis and a proportional hazard model. These included age at onset, prodromal diarrhea (D), leukocyte count, central nervous system (CNS) involvement, and evidence of Shiga toxin-producing Escherichia coli (STEC) infection. Three hundred and eighty-seven HUS cases were reported; 276 were investigated for STEC infection and 189 (68%) proved positive. Age at onset, leukocyte count, and CNS involvement were not associated with the time to recovery. Absence of prodromal D and lack of evidence of STEC infection were independently associated with a poor renal prognosis; only 34% of patients D-STEC- recovered normal renal function compared with 65%-76% of D+STEC+, D+STEC- and D-STEC+ patients. In conclusion, absence of both D and evidence of STEC infection are needed to identify patients with HUS and worst prognosis, while D- but STEC+ patients have a significantly better prognosis.
引用
收藏
页码:1229 / 1235
页数:7
相关论文
共 42 条
[1]   The United States national prospective hemolytic uremic syndrome study: Microbiologic, serologic, clinical, and epidemiologic findings [J].
Banatvala, N ;
Griffin, PM ;
Greene, KD ;
Barrett, TJ ;
Bibb, WF ;
Green, JH ;
Wells, JG .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07) :1063-1070
[2]   ENZYME-LINKED IMMUNOSORBENT ASSAYS FOR DETECTING ANTIBODIES TO SHIGA-LIKE TOXIN-I, SHIGA-LIKE TOXIN-II, AND ESCHERICHIA-COLI O157-H7 LIPOPOLYSACCHARIDE IN HUMAN SERUM [J].
BARRETT, TJ ;
GREEN, JH ;
GRIFFIN, PM ;
PAVIA, AT ;
OSTROFF, SM ;
WACHSMUTH, IK .
CURRENT MICROBIOLOGY, 1991, 23 (04) :189-195
[3]  
CAMBA L, 1985, HAEMATOLOGICA, V70, P341
[4]   COMMUNITY-WIDE OUTBREAK OF HEMOLYTIC-UREMIC SYNDROME-ASSOCIATED WITH NON-O157 VEROCYTOTOXIN-PRODUCING ESCHERICHIA-COLI [J].
CAPRIOLI, A ;
LUZZI, I ;
ROSMINI, F ;
RESTI, C ;
EDEFONTI, A ;
PERFUMO, F ;
FARINA, C ;
GOGLIO, A ;
GIANVITI, A ;
RIZZONI, G .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) :208-211
[5]   Non-O157 Shiga toxin-producing Escherichia coli infections in Europe [J].
Caprioli, A ;
Tozzi, AE ;
Rizzoni, G ;
Karch, H .
EMERGING INFECTIOUS DISEASES, 1997, 3 (04) :578-579
[6]   HEMOLYTIC-UREMIC SYNDROME AND VERO CYTOTOXIN-PRODUCING ESCHERICHIA-COLI INFECTION IN ITALY [J].
CAPRIOLI, A ;
LUZZI, I ;
ROSMINI, F ;
PASQUINI, P ;
CIRRINCIONE, R ;
GIANVITI, A ;
MATTEUCCI, MC ;
RIZZONI, G .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (01) :154-158
[7]   Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome [J].
Chandler, WL ;
Jelacic, S ;
Boster, DR ;
Ciol, MA ;
Williams, GD ;
Watkins, SL ;
Igarashi, T ;
Tarr, PI .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (01) :23-32
[8]   The serodiagnosis of infections caused by Verocytotoxin-producing Escherichia coli [J].
Chart, H ;
Jenkins, C .
JOURNAL OF APPLIED MICROBIOLOGY, 1999, 86 (05) :731-740
[9]  
COAD NAG, 1991, CLIN NEPHROL, V35, P10
[10]   Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France [J].
Decludt, B ;
Bouvet, P ;
Mariani-Kurkdjian, P ;
Grimont, F ;
Grimont, PAD ;
Hubert, B ;
Loirat, C .
EPIDEMIOLOGY AND INFECTION, 2000, 124 (02) :215-220